scholarly journals A Single-Arm, Prospective, Phase II Study of Cisplatin Plus Weekly Docetaxel as First-Line Therapy in Patients with Metastatic or Recurrent Salivary Gland Cancer

2021 ◽  
Author(s):  
Hye Ryeon Kim ◽  
Su Jin Lee ◽  
Sehhoon Park ◽  
Hyun Ae Jung ◽  
Se-Hoon Lee ◽  
...  
Keyword(s):  
Salivary Gland ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Salivary Gland Cancer ◽  
First Line ◽  
Weekly Docetaxel ◽  
First Line Therapy ◽  
Line Therapy ◽  
Prospective Phase

Phase II study of trastuzumab and cisplatin as first-line therapy in patients with HER2-positive advanced gastric or gastroesophageal junction cancer

2011 ◽  
Vol 13 (3) ◽  
pp. 179-184 ◽  
Author(s):  
Cristina Grávalos ◽  
Carlos Gómez-Martín ◽  
Fernando Rivera ◽  
Inmaculada Alés ◽  
Bernardo Queralt ◽  
...  
Keyword(s):  
Phase Ii ◽  
Phase Ii Study ◽  
Gastroesophageal Junction ◽  
First Line ◽  
Her2 Positive ◽  
First Line Therapy ◽  
Gastroesophageal Junction Cancer ◽  
Line Therapy

Phase II Study of Irinotecan Plus Cisplatin as First Line therapy in Extensive Small-Cell Lung Cancer

2006 ◽  
Vol 61 (2) ◽  
pp. 143
Author(s):  
Ki Eun Hwang ◽  
So Young Kim ◽  
Jong Hoon Jung ◽  
Seong Hoon Park ◽  
Jung Hyun Park ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Study ◽  
Small Cell ◽  
Small Cell Lung ◽  
First Line ◽  
First Line Therapy ◽  
Line Therapy

scholarly journals Phase Ii Study of Individualized Sunitinib As First-Line Therapy for Metastatic Clear Cell Renal Cell Cancer (Mrcc)

2014 ◽  
Vol 25 ◽  
pp. iv292 ◽  
Author(s):  
G.A. Bjarnason ◽  
B. Naveen ◽  
E. Winquist ◽  
C.K. Kollmannsberger ◽  
C. Canil ◽  
...  
Keyword(s):  
Phase Ii ◽  
Renal Cell Cancer ◽  
Renal Cell ◽  
Clear Cell ◽  
Phase Ii Study ◽  
Cell Cancer ◽  
First Line ◽  
First Line Therapy ◽  
Line Therapy
Sign in / Sign up

Export Citation Format

Share Document